ALS Advances Unite Patients and Pharma on Novel Targets, Biomarker Breakthroughs
In this episode, you'll be listening to Indu Navar, CEO and founder of EverythingALS and Dr. Olga Uspenskaya, chief medical officer at VectorY Therapeutics. We'll be speaking about patient-pharma collaborations accelerating trials and hope, advances in ALS biology understanding and biomarker-driven endpoints.
Host
Jennifer Smith-Parker, Director of Insights, BioSpace
Guests
Indu Navar, CEO and Founder, EverythingALS
Dr. Olga Uspenskaya, Chief Medical Officer, VectorY Therapeutics
Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.